A1CMV
4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-diphenylbutanamide
| Created: | 2025-08-07 |
| Last modified: | 2025-11-12 |
Find Related PDB Entry |
|---|
Find related ligands:Help |
|---|
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 67 |
| Chiral Atom Count | 0 |
| Bond Count | 70 |
| Aromatic Bond Count | 18 |
Chemical Component Summary | |
|---|---|
| Name | 4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-diphenylbutanamide |
| Systematic Name (OpenEye OEToolkits) | 4-[4-(4-chlorophenyl)-4-oxidanyl-piperidin-1-yl]-~{N},~{N}-dimethyl-2,2-diphenyl-butanamide |
| Formula | C29 H33 Cl N2 O2 |
| Molecular Weight | 477.038 |
| Type | NON-POLYMER |
Chemical Descriptors | |||
|---|---|---|---|
| Type | Program | Version | Descriptor |
| SMILES | ACDLabs | 14.52 | CN(C)C(=O)C(CCN1CCC(O)(CC1)c1ccc(Cl)cc1)(c1ccccc1)c1ccccc1 |
| SMILES | CACTVS | 3.385 | CN(C)C(=O)C(CCN1CCC(O)(CC1)c2ccc(Cl)cc2)(c3ccccc3)c4ccccc4 |
| SMILES | OpenEye OEToolkits | 3.1.0.0 | CN(C)C(=O)C(CCN1CCC(CC1)(c2ccc(cc2)Cl)O)(c3ccccc3)c4ccccc4 |
| Canonical SMILES | CACTVS | 3.385 | CN(C)C(=O)C(CCN1CCC(O)(CC1)c2ccc(Cl)cc2)(c3ccccc3)c4ccccc4 |
| Canonical SMILES | OpenEye OEToolkits | 3.1.0.0 | CN(C)C(=O)C(CCN1CCC(CC1)(c2ccc(cc2)Cl)O)(c3ccccc3)c4ccccc4 |
| InChI | InChI | 1.06 | InChI=1S/C29H33ClN2O2/c1-31(2)27(33)29(24-9-5-3-6-10-24,25-11-7-4-8-12-25)19-22-32-20-17-28(34,18-21-32)23-13-15-26(30)16-14-23/h3-16,34H,17-22H2,1-2H3 |
| InChIKey | InChI | 1.06 | RDOIQAHITMMDAJ-UHFFFAOYSA-N |
Drug Info: DrugBank
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| DrugBank ID | DB00836 |
|---|---|
| Name | Loperamide |
| Groups |
|
| Description | Loperamide is an anti-diarrheal agent that is available as an over-the-counter product for treating diarrhea.[L42785] The drug was first synthesized in 1969 and used medically in 1976.[A251610] It is a highly lipophilic synthetic phenylpiperidine opioid that works by binding to mu-opioid receptors on intestinal muscles to decrease intestinal motility and electrolyte loss.[A251610] Loperamide has a chemical structure that is similar to diphenoxylate and haloperidol;[A6249] however, loperamide works on mu (μ)-opioid receptors to mediate its pharmacological actions.[A251610] |
| Synonyms |
|
| Brand Names |
|
| Indication | Loperamide is indicated for the relief of diarrhea, including Travelers’ Diarrhea.[L42785] As an off-label use, it is often used to manage chemotherapy-related diarrhea.[A251610] |
| Categories |
|
| ATC-Code |
|
| CAS number | 53179-11-6 |
Drug Targets
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| Name | Target Sequence | Pharmacological Action | Actions |
|---|---|---|---|
| Mu-type opioid receptor | MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRT... | unknown | agonist |
| Delta-type opioid receptor | MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAI... | unknown | agonist |
| Kappa-type opioid receptor | MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLE... | unknown | agonist |
| Pro-opiomelanocortin | MPRSCCSRSGALLLALLLQASMEVRGWCLESSQCQDLTTESNLLECIRAC... | unknown | modulator |
| Voltage-dependent P/Q-type calcium channel subunit alpha-1A | MARFGDEMPARYGGGGSGAAAGVVVGSGGGRGAGGSRQGGQPGAQRMYKQ... | unknown | blocker |
| View More | |||
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
| Resource Name | Reference |
|---|---|
| Pharos | CHEMBL841 |
| PubChem | 3955 |
| ChEMBL | CHEMBL841 |
| ChEBI | CHEBI:6532 |














